Human Responses to Influenza Vaccination
Demographics (2)
- age_group - Age group of the subject (phv00217675.v1.p1)
- sex - Sex of participant (phv00217674.v1.p1)
Other (14)
- ANALYTE_TYPE - Analyte Type (phv00217680.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00217668.v1.p1)
- prior_infection - Subjects have had prior flu infection, self-reported (phv00217676.v1.p1)
- prior_vaccination - Subjects have had prior flu vaccination, self-reported (phv00217677.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00217678.v1.p1)
- SAMPLE_ID - Sample ID (phv00217670.v1.p1)
- SAMPLE_USE - Sample Use (phv00217671.v1.p1)
- seroconverter - Influenza Seroconversion status (phv00217673.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00217672.v1.p1)
- SUBJECT_ID - Subject ID (phv00217669.v1.p1)
- SUBJECT_ID - Subject ID (phv00217667.v1.p1)
- TISSUE_TYPE - Tissue source of cells (phv00217679.v1.p1)
- vaccination_timepoint - Days following vaccination when sample was taken (phv00217682.v1.p1)
- vaccination_type - The type of vaccination used (phv00217681.v1.p1)